The Company confirms it has secured the support of the Municipality of Strathroy-Caradoc for its planned outdoor grow expected to be completed in two phases.
Read More
The FDA provided feedback supportive of CURE’s clinical development plans for its CUREfilm Blue, a soluble thin film for oral administration of sildenafil citrate (Viagra™) to treat erectile dysfunction (ED).
Read More
Inclusion in the ETF is as a significant milestone for ICC, as the Company continues to establish itself as the world’s premier, vertically integrated pure cannabis play.
Read More
The Company’s common shares have commenced trading today on the Toronto Stock Exchange (“TSX”)...
Read More
GW was awarded the voucher under a U.S. Food and Drug Administration (FDA) program intended to...
Read More
Get stock alerts, news & related alerts straight to your inbox!